We are live on
!
Find out more
WA1
Wimmer Associates 1 Portfolio holdings
AUM
$205M
1-Year Est. Return
21.23%
This Fund
S&P 500
This Quarter
Est. Return
+2.57%
1 Year Est. Return
+21.23%
3 Year Est. Return
+69.43%
5 Year Est. Return
+91.58%
10 Year Est. Return
+307.32%
AUM
$112M
AUM Growth
+$2.94M
(+2.7%)
Cap. Flow
+$748K
Cap. Flow
% of AUM
0.67%
Top 10 Holdings %
Top 10 Hldgs %
28.1%
Holding
114
New
5
Increased
56
Reduced
30
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco FTSE RAFI US 1000 ETF
PRF
|
+$734K |
| 2 |
Cognizant
CTSH
|
+$627K |
| 3 |
AGN
Allergan plc
AGN
|
+$513K |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$413K |
| 5 |
iShares S&P 500 Growth ETF
IVW
|
+$265K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AdvisorShares Insider Advantage ETF
SURE
|
+$1.29M |
| 2 |
Novartis
NVS
|
+$834K |
| 3 |
Oracle
ORCL
|
+$696K |
| 4 |
FFC
Flaherty & Crumrine Preferred and Income Securities Fund
FFC
|
+$554K |
| 5 |
EMC
EMC CORPORATION
EMC
|
+$464K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.27% |
| 2 | Industrials | 14.74% |
| 3 | Consumer Staples | 9.71% |
| 4 | Technology | 9.3% |
| 5 | Communication Services | 8.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EV
101
DELISTED
Eaton Vance Corp.
EV
| $238K | 0.21% |
6,731
+1
| +0% | +$35 |
|
102
Accenture
ACN
$95.1B
| $230K | 0.21% |
2,030
| – | – |
|
103
Public Storage
PSA
$60.7B
| $224K | 0.2% |
875
| – | – |
|
|
CELG
104
DELISTED
Celgene Corp
CELG
| $224K | 0.2% |
+2,270
| New | +$235K |
|
105
Colgate-Palmolive
CL
$73.6B
| $223K | 0.2% |
3,050
-350
| -10% | -$24.9K |
|
106
Berkshire Hathaway Class A
BRK.A
$1.07T
| $217K | 0.19% |
1
| – | – |
|
107
Ecolab
ECL
$76.4B
| $215K | 0.19% |
1,811
| – | – |
|
108
EOG Resources
EOG
$75B
| $206K | 0.18% |
+2,467
| New | +$198K |
|
109
Boeing
BA
$168B
| – | – |
-1,714
| Closed | -$218K |
|
|
FFC
110
Flaherty & Crumrine Preferred and Income Securities Fund
FFC
$773M
| – | – |
-27,200
| Closed | -$554K |
|
111
Generac Holdings
GNRC
$11.6B
| – | – |
-6,305
| Closed | -$235K |
|
|
112
AdvisorShares Insider Advantage ETF
SURE
$55.9M
| – | – |
-23,006
| Closed | -$1.29M |
|
113
VF Corp
VFC
$6.71B
| – | – |
-3,441
| Closed | -$210K |
|
Similar funds
LFA
TCM
PKC
WCM
KFA
TFM
F4L
CAM
Wimmer Associates 1's Q2 2016 Portfolio in Review
As of Q2 2016, Wimmer Associates 1 held 114 positions worth $112M, up 2.7% from $109M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Wimmer Associates 1's Q2 2016 filing shows 5 new, 56 increased, 30 reduced and 5 closed positions. Its largest new stake was Allergan plc: 2,225 shares worth $514K. The largest sale was AdvisorShares Insider Advantage ETF, an estimated $1.29M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Industrials and Consumer Staples.
- Wimmer Associates 1's largest Q2 2016 buy was Allergan plc: 2,225 shares worth $514K.
- Wimmer Associates 1 added most to Invesco FTSE RAFI US 1000 ETF in Q2 2016, an estimated $734K increase.
- Wimmer Associates 1's biggest Q2 2016 reduction was Novartis, cutting an estimated $834K.
- Wimmer Associates 1 fully exited AdvisorShares Insider Advantage ETF in Q2 2016, selling an estimated $1.29M.
- Wimmer Associates 1's ten largest holdings make up 28% of its $112M portfolio in Q2 2016.
- Wimmer Associates 1 opened 5 new positions and closed 5 in Q2 2016.
- Wimmer Associates 1's portfolio value rose 2.7% quarter-over-quarter to $112M.
Based on Wimmer Associates 1's 13F filing for Q2 2016, filed 11 Aug 2016.